Fenwick Represents Propeller Health in $21.5 Million Series C Financing

October 21, 2016

Fenwick & West represented Propeller Health, a leading digital solution for respiratory medicine, in its $21.5 million Series C financing. The funding included new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, and existing investors Safeguard Scientifics and Social Capital.

The company will use the funds to expand its digitally-guided therapy platform and modernize the management of respiratory disease. More information about Propeller Health’s $21.5 million Series C financing can be obtained from the company press release.

The Fenwick transaction team was led by corporate lawyers Michael EsquivelJosé–Daniel Paramés and Hans Andersson; and technology transactions attorney Stefano Quintini.